Clinical trial
A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma
NCT07334301 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma
- Lead sponsor
- University of Birmingham
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- November 11, 2024
- Completion date
- December 31, 2030
- Enrollment
- 160 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed neuroblastoma